Complicated: A phase 1 trial has been completed and reported, but a phase 2 trial comparing amn107, or nilotinib, to imatinib (gleevec), was closed early due to interim analysis showing nonsuperiority. It is being tried in combo with Gleevec in other trials. Fox chase has a trial. Nccn guidelines accept nilotinib as a treatment option but it's use is still off-label for now in gist.
Answered 10/3/2016
5.7k views
Amn-107 is TASIGNA (nilotinib): Amn 107 tasigna (nilotinib) is used for CML ( chronic myeloidleukemia ) especially if resistant to Gleevec fda did not aprove for gastointestinal stromal cell tumors ( gist ).
Answered 6/25/2014
5.7k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question